Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review
Whittle, S. L.;Hughes, R. A.;
rheumatology2004Vol. 43pp. 267-271
153
l.2004rheumatologyfolate
Abstract
Abstract. Objectives. The folate antagonist methotrexate (MTX) has become established as the most commonly used disease-modifying anti-rheumatic drug (DMARD) in